Showing results (191-200 of 247) with videos related to
Sort By:
Pageof 25
Contemporary Clinical Trials Communications|October 28, 2025
Protocol for the rural engagement in TelemedTeam for options in obesity treatment solutions (RE-TOOL): Cluster randomized trial investigating team-based telemedicine in rural primary careAlexandra R Brown, Edward F Ellerbeck, Debra K Sullivan, et al.Contemporary Clinical Trials Communications|June 9, 2020
Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated TrialsDinesh Pal Mudaranthakam, Milind A Phadnis, Ron Krebill, et al.Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2001
Adenovirus infections in adult recipients of blood and marrow transplantsA M La Rosa, R E Champlin, N Mirza, et al.Blood|December 9, 2000
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor programS M Davies, C Kollman, C Anasetti, et al.Trials|August 16, 2017
Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trialBabalola Faseru, Edward F Ellerbeck, Delwyn Catley, et al.Statistics in Medicine|June 17, 2024
Improved mortality analysis in early-phase dose-ranging clinical trials for emergency medical diseases using Bayesian time-to-event models with active comparatorsXiaosong Shi, Jo A Wick, Renee' L Martin, et al.Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.The American Journal of Clinical Nutrition|February 22, 2013
DHA supplementation and pregnancy outcomesSusan E Carlson, John Colombo, Byron J Gajewski, et al.Pageof 25